Literature DB >> 10551503

Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4)

O Meyer, A Salama, N Pittet, P Schwind.   

Abstract

Early and acute diagnosis is needed to prevent thromboembolic complications in heparin-induced thrombocytopenia. We developed a particle agglutination assay that allows the detection of such antibodies within 20 min.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10551503     DOI： 10.1016/S0140-6736(99)03625-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Laboratory testing for heparin-induced thrombocytopenia.

Authors:  T E Warkentin
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 2.  Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors:  Albrecht Leo; Susanne Winteroll
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

3.  Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies.

Authors:  Christian Schreiber; W Dietrich; S Braun; M Kostolny; A Eicken; R Lange
Journal:  Clin Res Cardiol       Date:  2006-06-20       Impact factor: 5.460

Review 4.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.

Authors:  Vanessa Nellen; Irmela Sulzer; Gabriela Barizzi; Bernhard Lämmle; Lorenzo Alberio
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

6.  Platelet factor 4/heparin-particle gel immunoassay (PaGIA) is a weak method for heparin-induced thrombocytopenia (HIT) evaluation of post cardio-pulmonary bypass surgery patients.

Authors:  Chezi Ganzel; Jacob Rowe; David Raveh
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

7.  Use of the ID-PaGIA Heparin/PF4 Antibody Test as a screening test for heparin/platelet factor 4 antibodies.

Authors:  Erwin Strobel
Journal:  Blood Transfus       Date:  2016-06-24       Impact factor: 3.443

8.  Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.

Authors:  Jovan Perunicic; Nebojsa M Antonijevic; Predrag Miljic; Valentina Djordjevic; Danijela Mikovic; Mirjana Kovac; Milan Djokic; Igor Mrdovic; Aleksandra Nikolic; Zorana Vasiljevic
Journal:  J Thromb Thrombolysis       Date:  2007-09-09       Impact factor: 2.300

9.  Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.

Authors:  Tamam Bakchoul; Andreas Greinacher
Journal:  Ther Adv Hematol       Date:  2012-08

Review 10.  Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results.

Authors:  Gowthami M Arepally; Marcie J Hursting
Journal:  J Thromb Thrombolysis       Date:  2008-03-28       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.